Inspirion Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $347K | Sell |
6,310
-10
| -0.2% | -$550 | 0.05% | 119 |
|
|
2025
Q1 | $447K | Buy |
6,320
+725
| +13% | +$51.3K | 0.06% | 102 |
|
|
2024
Q4 | $380K | Sell |
5,595
-7,863
| -58% | -$534K | 0.05% | 110 |
|
|
2024
Q3 | $946K | Hold |
13,458
| – | – | 0.13% | 62 |
|
|
2024
Q2 | $1.11M | Buy |
13,458
+504
| +4% | +$41.5K | 0.17% | 53 |
|
|
2024
Q1 | $1.13M | Buy |
12,954
+71
| +0.6% | +$6.2K | 0.19% | 54 |
|
|
2023
Q4 | $1.26M | Buy |
12,883
+260
| +2% | +$25.5K | 0.23% | 48 |
|
|
2023
Q3 | $1.12M | Buy |
12,623
+725
| +6% | +$64.1K | 0.22% | 48 |
|
|
2023
Q2 | $1.03M | Buy |
11,898
+58
| +0.5% | +$5.03K | 0.2% | 53 |
|
|
2023
Q1 | $1.15M | Hold |
11,840
| – | – | 0.23% | 44 |
|
|
2022
Q4 | $1.23M | Buy |
11,840
+1,000
| +9% | +$103K | 0.26% | 40 |
|
|
2022
Q3 | $919K | Buy |
10,840
+450
| +4% | +$38.2K | 0.21% | 48 |
|
|
2022
Q2 | $861K | Buy |
10,390
+2,564
| +33% | +$212K | 0.19% | 54 |
|
|
2022
Q1 | $603K | Buy |
7,826
+2,300
| +42% | +$177K | 0.12% | 60 |
|
|
2021
Q4 | $488K | Sell |
5,526
-129
| -2% | -$11.4K | 0.1% | 62 |
|
|
2021
Q3 | $437K | Buy |
5,655
+557
| +11% | +$43K | 0.1% | 62 |
|
|
2021
Q2 | $425K | Buy |
5,098
+44
| +0.9% | +$3.67K | 0.1% | 61 |
|
|
2021
Q1 | $382K | Buy |
+5,054
| New | +$382K | 0.1% | 65 |
|